X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $32.51 million. The enterprise value is $8.54 million.
Important Dates
The next confirmed earnings date is Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 173.66 million shares outstanding. The number of shares has increased by 13.08% in one year.
| Current Share Class | 173.66M |
| Shares Outstanding | 173.66M |
| Shares Change (YoY) | +13.08% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 5.67% |
| Owned by Institutions (%) | 40.27% |
| Float | 131.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.72 |
| Forward PS | 2.79 |
| PB Ratio | 1.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.34 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 3.53.
| Current Ratio | 3.41 |
| Quick Ratio | 3.16 |
| Debt / Equity | 3.53 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -16.13 |
Financial Efficiency
Return on equity (ROE) is -102.26% and return on invested capital (ROIC) is -84.32%.
| Return on Equity (ROE) | -102.26% |
| Return on Assets (ROA) | -60.18% |
| Return on Invested Capital (ROIC) | -84.32% |
| Return on Capital Employed (ROCE) | -124.51% |
| Revenue Per Employee | $17,881 |
| Profits Per Employee | -$261,888 |
| Employee Count | 143 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, XFOR has paid $310,000 in taxes.
| Income Tax | 310,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.78% in the last 52 weeks. The beta is 0.58, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -84.78% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.53 |
| Relative Strength Index (RSI) | 31.36 |
| Average Volume (20 Days) | 1,791,552 |
Short Selling Information
The latest short interest is 8.08 million, so 4.65% of the outstanding shares have been sold short.
| Short Interest | 8.08M |
| Short Previous Month | 8.64M |
| Short % of Shares Out | 4.65% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 4.83 |
Income Statement
In the last 12 months, XFOR had revenue of $2.56 million and -$37.45 million in losses. Loss per share was -$0.19.
| Revenue | 2.56M |
| Gross Profit | 1.76M |
| Operating Income | -141.40M |
| Pretax Income | 17.73M |
| Net Income | -37.45M |
| EBITDA | -140.61M |
| EBIT | -141.40M |
| Loss Per Share | -$0.19 |
Full Income StatementBalance Sheet
The company has $102.06 million in cash and $78.09 million in debt, giving a net cash position of $23.97 million or $0.14 per share.
| Cash & Cash Equivalents | 102.06M |
| Total Debt | 78.09M |
| Net Cash | 23.97M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 22.15M |
| Book Value Per Share | 0.13 |
| Working Capital | 79.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$130.90 million and capital expenditures -$326,000, giving a free cash flow of -$131.23 million.
| Operating Cash Flow | -130.90M |
| Capital Expenditures | -326,000 |
| Free Cash Flow | -131.23M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
| Gross Margin | 68.83% |
| Operating Margin | -5,529.96% |
| Pretax Margin | -1,452.48% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.08% |
| Shareholder Yield | -13.08% |
| Earnings Yield | -115.20% |
| FCF Yield | -403.66% |
Analyst Forecast
The average price target for XFOR is $2.83, which is 1,411.75% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.83 |
| Price Target Difference | 1,411.75% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 153.60% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
XFOR has an Altman Z-Score of -6.79. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.79 |
| Piotroski F-Score | n/a |